AtosibanHormone TherapySafety Rating 8/10
Primary research areaPreterm labor suppression (not US approved)
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range6.75 mg IV bolus then 18 mcg/min infusion
AdministrationIntravenous
Safety8/10 · EMA-approved (Tractocile)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Atosiban
Mechanism of action
Oxytocin receptor antagonist; competitively inhibits myometrial contractions
Safety profile
Nausea, headache, injection site reactions · Approved in Europe for preterm labor; well-tolerated in clinical trials
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Atosiban below your target.
Related pages